MIT scientist Deblina Sarkar invents injectable microscopic chips capable of precise brain-targeted therapy without surgery.

Taken together, the energy-related elements go a long way toward helping wean us off planet-warming fossil fuels, despite ...

Brain disorders already affect around 165 million people in Europe and cost an estimated €800 billion every year in health ...

The biotechnology firm Bionxt Solutions has reported a significant achievement in its Multiple Sclerosis (MS) therapy program. Recent preclinical study results for its novel Cladribine formulation ...

As biotechs faced investors at the J.P. Morgan Healthcare Conference this week, they emphasized agreement with the FDA on ...

Zura Bio Limited ("Zura" or the "Company"), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and ...

Mediterranean, plant-based, and anti-inflammatory diets are associated with reduced C-reactive protein levels in people with multiple sclerosis.

Multiple sclerosis may quietly damage the brain for years before symptoms appear, and scientists can now see it coming.

A look at Amyotrophic Lateral Sclerosis (ALS), focusing on motor neuron degeneration, sporadic versus familial ...

A team at Johns Hopkins Medicine has focused their work on myelin development using oligodendrocytes to help study conditions like MS.

Immediately after occupational therapy (OT), people with multiple sclerosis may show small improvements in daily functioning and mental health-related quality of life (HR-QoL), but OT may have little ...

Advances in disease-modifying therapies, diagnostics, and comorbidity management have increased life expectancy in people with multiple sclerosis (MS), ...